b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">31670408</PMID>\n        <DateCompleted>\n            <Year>2020</Year>\n            <Month>06</Month>\n            <Day>15</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>06</Month>\n            <Day>15</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1537-2995</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>59</Volume>\n                    <Issue>12</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>12</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Transfusion</Title>\n                <ISOAbbreviation>Transfusion</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Cold reacting anti-M causing delayed hemolytic disease of the newborn.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>3575-3579</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1111/trf.15578</ELocationID>\n            <Abstract>\n                <AbstractText Label="BACKGROUND">Hemolytic disease of the fetus and newborn (HDFN) is due to passively transferred maternal antibodies directed against fetal red blood cell (RBC) antigens and can lead to severe morbidity and mortality. Anti-M is usually a naturally occurring antibody of low clinical significance, although occasionally severe cases of HDFN are seen.</AbstractText>\n                <AbstractText Label="CASE REPORTS">Two M+ sisters are presented, each developing hemolysis during the first 2\xe2\x80\x89weeks of life due to maternal anti-M, resulting in severe anemia and requiring blood transfusion. RBC agglutination was observed in peripheral blood samples of both infants at room temperature with dissociation at 37\xc2\xb0C. Maternal anti-M detected by column indirect agglutination technique, was of low titer (1:16) and demonstrated low thermal amplitude, reacting in saline at 4\xc2\xb0C but was not detectable in saline at 37\xc2\xb0C.</AbstractText>\n                <AbstractText Label="CONCLUSIONS">Anti-M of low thermal amplitude may cause hemolytic disease of the newborn with laboratory features resembling cold agglutinin disease.</AbstractText>\n                <CopyrightInformation>\xc2\xa9 2019 AABB.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Crispin</LastName>\n                    <ForeName>Philip</ForeName>\n                    <Initials>P</Initials>\n                    <Identifier Source="ORCID">0000-0002-4124-4971</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Haematology Department, ACT Pathology, Garran, ACT Australia.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Clinical Haematology, Canberra Hospital, Garran, ACT Australia.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Medical School, Australian National University, Acton ACT Australia.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Sliwinski</LastName>\n                    <ForeName>Kelly</ForeName>\n                    <Initials>K</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Haematology Department, ACT Pathology, Garran, ACT Australia.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Wilson</LastName>\n                    <ForeName>Caroline</ForeName>\n                    <Initials>C</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Clinical Haematology, Canberra Hospital, Garran, ACT Australia.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Lennard</LastName>\n                    <ForeName>Samantha</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Haematology Department, ACT Pathology, Garran, ACT Australia.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>DeSouza</LastName>\n                    <ForeName>Marianne</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Haematology Department, ACT Pathology, Garran, ACT Australia.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Sethna</LastName>\n                    <ForeName>Farah</ForeName>\n                    <Initials>F</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Maternofetal Medicine Unit, Centenary Hospital for Women and Children, Garran, ACT Australia.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D002363">Case Reports</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>10</Month>\n                <Day>31</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>United States</Country>\n            <MedlineTA>Transfusion</MedlineTA>\n            <NlmUniqueID>0417360</NlmUniqueID>\n            <ISSNLinking>0041-1132</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D007075">Immunoglobulin M</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000744" MajorTopicYN="N">Anemia, Hemolytic, Autoimmune</DescriptorName>\n                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D001803" MajorTopicYN="N">Blood Transfusion</DescriptorName>\n                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D003298" MajorTopicYN="N">Coombs Test</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D004899" MajorTopicYN="N">Erythroblastosis, Fetal</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006461" MajorTopicYN="N">Hemolysis</DescriptorName>\n                <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName>\n                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D007075" MajorTopicYN="N">Immunoglobulin M</DescriptorName>\n                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D013696" MajorTopicYN="N">Temperature</DescriptorName>\n            </MeshHeading>\n        </MeshHeadingList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2019</Year>\n                <Month>01</Month>\n                <Day>31</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2019</Year>\n                <Month>09</Month>\n                <Day>06</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>09</Month>\n                <Day>15</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>11</Month>\n                <Day>2</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2020</Year>\n                <Month>6</Month>\n                <Day>17</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>11</Month>\n                <Day>1</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31670408</ArticleId>\n            <ArticleId IdType="doi">10.1111/trf.15578</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Title>REFERENCES</Title>\n            <Reference>\n                <Citation>Makroo RN, Rajput S, Agarwal S, et al. Prevalence of irregular red cell antibody in healthy blood donors attending a tertiary care hospital in North India. Asian J Transfus Sci 2018;12:17-20.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Smith ML, Beck ML. The immunoglobulin structure of human anti-M agglutinins. Transfusion 1979;19:472-4.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Makroo RN, Arora B, Bhatia A, et al. Clinical significance of antibody specificities to M, N and Lewis blood group system. Asian J Transfus Sci 2014;8:96-9.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Smith HM, Shirey RS, Thoman SK, et al. Prevalence of clinically significant red blood cell alloantibodies in pregnant women at a large tertiary-care facility. Immunohematology 2013;29:127-30.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Bollason G, Hjartardottir H, Jonsson T, et al. Red blood cell alloimmunization in pregnancy during the years 1996-2015 in Iceland: a nation-wide population study. Transfusion 2017;57:2578-85.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Koelewijn JM, Vrijkotte TGM, Van Der Schoot CE, et al. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands. Transfusion 2008;48:941-52.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Stetson B, Scrape S, Markham KB. Anti-M alloimmunization: management and outcome at a single institution. AJP Rep 2017;7:e205-e10.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>De Young-Owens A, Kennedy M, Rose RL, et al. Anti-M isoimmunization: management and outcome at the Ohio State University from 1969 to 1995. Obstet Gynecol 1997;90:962-6.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Parry-Jones N, Gore ME, Taylor J, et al. Delayed haemolytic transfusion reaction caused by anti-M antibody in a patient receiving interleukin-2 and interferon for metastatic renal cell cancer. Clin Lab Haematol 1999;21:407-8.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Sancho JM, Pujol M, Fernandez F, et al. Delayed haemolytic transfusion reaction due to anti-M antibody. Br J Haematol 1998;103:268-9.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Yasuda H, Ohto H, Nollet KE, et al. Hemolytic disease of the fetus and newborn with late-onset anemia due to anti-M: a case report and review of the Japanese literature. Transfus Med Rev 2014;28:1-6.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Wikman A, Edner A, Gryfelt G, et al. Fetal hemolytic anemia and intrauterine death caused by anti-M immunization. Transfusion 2007;47:911-7.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Bowley CC, Dunsford I. The agglutinin anti-M associated with pregnancy; report on two cases. Br Med J 1949;2:681-2.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Hubinont C, Delens G, Vanalbada De Haan Hettema J, et al. Successful management of a severe anti-M alloimmunization during pregnancy. Eur J Obstet Gynecol Reprod Biol 2017;217:175-6.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Ishida A, Ohto H, Yasuda H, et al. Anti-M antibody induced prolonged anemia following hemolytic disease of the newborn due to erythropoietic suppression in 2 siblings. J Pediatr Hematol Oncol 2015;37:e375-7.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Turkmen T, Qiu D, Cooper N, et al. Red blood cell alloimmunization in neonates and children up to 3\xe2\x80\x89years of age. Transfusion 2017;57:2720-6.</Citation>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'